Research progress on related factors of cardiovascular events in peritoneal dialysis

doi:10.3877/cma.j.issn.2095-3216.2020.06.005

Abstract

Abstract:

End-stage renal disease is the end-stage of chronic kidney disease and requires blood purification or kidney transplantation to maintain the life of the patient. As a method of blood purification, peritoneal dialysis (PD) has the advantages of simple operation, home dialysis, and protection of residual renal function, etc. Nevertheless, the mortality rate of peritoneal dialysis patients is still high, and the occurrence of cardiovascular events is the main cause of death in PD patients. This article mainly reviewed the correlation between red blood cell distribution width (RDW), serum total bilirubin (TBIL), serum uric acid, aspartate aminotransferase/alanine aminotransferase ratio (AST/ALT), soluble suppression of tumorigenicity 2(sST2), and cardiovascular events in peritoneal dialysis, in order to provide more references for clinical work.

Key words: Peritoneal dialysis, Cardiovascular events, Influencing factors, Correlation

Xiaofei Wang, Hongbin Zou. Research progress on related factors of cardiovascular events in peritoneal dialysis[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2020, 09(06): 264-266.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsbyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3216.2020.06.005

https://zhsbyjdzzz.cma-cmc.com.cn/EN/Y2020/V09/I06/264

References 30

[1]	陈娜，陈孟华. 腹膜透析心血管疾病影响因素研究进展[J]. 中国血液净化，2014, 13(7): 523-525, 530.
[2]	曾丙香，陈岩冰，张莉，等. 腹膜透析患者心血管事件的危险因素分析[J]. 江西医药，2018, 53(10): 1101-1105.
[3]	胡绍兰. 维持性腹膜透析患者心血管钙化的相关因素研究[D]. 昆明医科大学，2019.
[4]	Lippi G, Cervellin G. Risk assessment of post-infarction heart failure. Systematic review on the role of emerging biomarkers [J]. Crit Rev Clin Lab Sci, 2014, 51(1): 13-29.
[5]	逯春鹏，满秀荣，穆纳新，等. 红细胞分布宽度与急性ST段抬高型心肌梗死长期预后相关性研究[J]. 中华实用诊断与治疗杂志，2019, 33(6): 550-553.
[6]	张茜，周伟燕，王萌，等. 急性缺血性脑卒中患者RDW、UA水平变化及应用价值研究[J]. 国际检验医学杂志，2020, 41(12): 1468-1472.
[7]	黄思博，黄盛玲，董向楠，等. 红细胞分布宽度：慢性肾脏病心血管疾病的预测指标[J]. 临床医学工程，2019, 26(S1): 45-48.
[8]	Cao HX, Zhao XD, Yan L, et al. Correlation between red blood cell distribution width and cardiovascular events in the patients receiving peritoneal dialysis: a Strobe-compliant article [J]. Medicine, 2019, 98(6): e14376.
[9]	赵心迪，阎磊，范晓光，等. 红细胞分布宽度与腹膜透析患者心血管事件相关性[J]. 中华实用诊断与治疗杂志，2017, 31(4): 368-371.
[10]	邹原方，邓惠钊，梁翔，等. 红细胞分布宽度对维持性腹膜透析患者心血管疾病的预测价值[J]. 中国医学创新，2020, 17(18): 1-5.
[11]	贺奇恩，应光辉，夏敏. RDW与腹膜透析患者不良心血管事件的相关性分析[J]. 重庆医学，2020, 49(6): 899-904.
[12]	陆正梅，蒋红樱，周晓萍，等. 持续非卧床腹膜透析患者红细胞分布宽度与左心室肥厚的相关性探讨[J]. 西北国防医学杂志，2020, 41(1): 36-41.
[13]	孟婕，王晓阳，李肖肖，等. 红细胞分布宽度与持续不卧床腹膜透析患者死亡的相关性[J]. 中华肾脏病杂志，2018, 34(2): 87-93.
[14]	Zhan X, Yang M, Chen Y, et al. Relationship between serum bilirubin levels and mortality in patients on peritoneal dialysis [J]. Ren Fail, 2019, 41(1): 532-539.
[15]	杨天贵，付鹏，许长禄，等. 血清总胆红素水平与冠状动脉介入围手术期心血管事件的关系[J]. 中国动脉硬化杂志，2016, 24(3): 281-284.
[16]	Yu J, Han JL, Wang GS, et al. Serum total bilirubin levels and disease severity in patients with stable coronary artery disease [J]. Herz, 2017, 42(4): 403-410.
[17]	范瑾瑾，刘新辉，易春燕，等. 低血清总胆红素水平与腹膜透析患者全因死亡与心血管事件死亡的相关性[J]. 中华肾脏病杂志，2018, 34(11): 801-808.
[18]	李静，李洛华，蒋红樱，等. 维持性腹膜透析患者血清总胆红素水平与全因死亡、心血管事件死亡的相关性[J]. 临床肾脏病杂志，2020, 20(2): 114-120.
[19]	王丹晨，禹松林，夏良裕，等. 高尿酸血症与心血管疾病危险因素的相关性[J]. 临床检验杂志，2020, 38(5): 384-386.
[20]	Wu J, Lei G, Wang X, et al. Asymptomatic hyperuricemia and coronary artery disease in elderly patients without comorbidities [J]. Oncotarget, 2017, 8(46): 80688-80699.
[21]	张启龙，王俊倪，王耀敏，等. 维持性腹膜透析患者血清尿酸水平对全因死亡及心血管事件死亡的影响[J]. 中华肾脏病杂志，2018, 34(11): 809-815.
[22]	张启龙. 维持性腹膜透析患者血清尿酸水平对全因死亡及心血管事件死亡的影响[D]. 浙江大学，2019.
[23]	Xiang S, Zhang X, Xie X, et al. High serum uric acid level is a mortality risk factor in peritoneal dialysis patients: a retrospective cohort study [J]. Nutr Metab (Lond), 2019, 16: 52.
[24]	Weng SF, Kai J, Guha IN, et al. The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk assessment [J]. Open Heart, 2015, 2(1): e000272.
[25]	Feng X, Wen Y, Peng FF, et al. Association between aminotransferase/alanine aminotransferase ratio and cardiovascular disease mortality in patients on peritoneal dialysis: a multi-center retrospective study [J]. BMC Nephrol, 2020, 21(1): 209.
[26]	吴桂颖，胡立群，李红旗. 血清可溶性人基质裂解素2、半乳糖凝集素-3和生长分化因子-15在住院心力衰竭患者中的预后价值[J]. 中华心力衰竭和心肌病杂志，2019, 3(4): 193-197.
[27]	Choi YB, Lee MJ, Park JT, et al. Prognostic value of soluble ST2 and soluble LR11 on mortality and cardiovascular events in peritoneal dialysis patients [J]. BMC Nephrol, 2020, 21(1): 228.
[28]	Chen T, Yang M. Platelet-to-lymphocyte ratio is associated with cardiovascular disease in continuous ambulatory peritoneal dialysis patients [J]. Int Immunopharmacol, 2020, 78: 106063.
[29]	Zhan X, Pan D, Wei X, et al. Monocyte to high-density lipoprotein ratio and cardiovascular events in patients on peritoneal dialysis [J]. Nutr Metab Cardiovasc Dis, 2020, 30(7): 1033-1036.
[30]	范阳贞，赵瑛瑛. 腹膜透析患者Lp-PLA2和SAA水平及与心血管风险的研究[J]．医药论坛杂志，2019, 40(3): 18-21.

Please choose a citation manager

Content to export